Cargando…

Modeling Time Effects in Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema – A Mixed Model Analysis of Real-World Data

Objective The primary objective of this study is to present real-world data on the efficiency of diabetic macular edema (DMO) treatment with anti-vascular endothelial growth factor (anti-VEGF) agents. Methods The study included 86 unique eyes from 86 patients who received ≥3 anti-VEGF injections; th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mylona, Ioanna, Tsinopoulos, Ioannis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Ophthalmology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515791/ https://www.ncbi.nlm.nih.gov/pubmed/32983733 http://dx.doi.org/10.7759/cureus.10043

Ejemplares similares

Intravitreal Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapy for Valsalva Related Sub-internal Limiting Membrane (Sub-ILM) Macular Haemorrhage: A Case Report
por: Nur-Najwa, Suhaifi, et al.
Publicado: (2023)

Response of Pediatric Choroidal Neovascularization to Anti-Vascular Endothelial Growth Factor
por: Ruparelia, Sunil, et al.
Publicado: (2021)

Anti-vascular Endothelial Growth Factor Outpatient Treatment Patterns in Patients with Exudative Age-related Macular Degeneration from a Japanese Hospital Claims Database
por: Iida, Tomohiro, et al.
Publicado: (2014)

Staphylococcus lugdunensis Endophthalmitis Following Intravitreal Anti-vascular Endothelial Growth Factor Injections
por: Ahmed, Umar, et al.
Publicado: (2022)

A Comparative Study of Ganglion Cell Complex Thickness Changes in Diabetic Macular Edema and Central Retinal Vein Occlusion Macular Edema: An Optical Coherence Tomography Study
por: Mathurkar, Swapneel, et al.
Publicado: (2022)

Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis
por: Pham, Ba', et al.
Publicado: (2019)

Aflibercept for the Treatment of Macular Edema Secondary to Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome
por: López Fontanet, José, et al.
Publicado: (2023)

Review of Studies Comparing Panretinal Photocoagulation and Anti-Vascular Endothelial Growth Factor Therapy in the Treatment of Proliferative Diabetic Retinopathy
por: Gunasekaran, Thiruvarasu, et al.
Publicado: (2022)

Progress of Diabetic Macular Edema after Loading Injection of Anti-Vascular Endothelial Growth Factor Agents in Real-World Cases
por: Enomoto, Hiroko, et al.
Publicado: (2022)

Real-World Persistence and Treatment Interval in Patients with Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factors in the USA
por: Bakri, Sophie J., et al.
Publicado: (2023)

Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study
por: Jern, Iréne, et al.
Publicado: (2022)

Anti-vascular endothelial growth factor treatment in diabetic macular edema
por: Kim, Moosang
Publicado: (2016)

Persistent Macular Edema in a Pediatric Vogt-Koyanagi-Harada Disease Patient: A Case Report
por: Almasoudi, Eid A, et al.
Publicado: (2022)

How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review
por: Taylor, Deanna J, et al.
Publicado: (2016)

Reoperations After Cataract Surgery: Is the Incidence Predictable Through a Risk Factor Stratification System?
por: Oustoglou, Eirini, et al.
Publicado: (2020)

Deep Learning Classification of Drusen, Choroidal Neovascularization, and Diabetic Macular Edema in Optical Coherence Tomography (OCT) Images
por: Riazi Esfahani, Parsa, et al.
Publicado: (2023)

Anterior Chamber Paracentesis Offers a Less Painful Experience During Intravitreal Anti-vascular Endothelial Growth Factor Administration: An Intraindividual Study
por: Karakahya, Refika Hande
Publicado: (2021)

Patient Adherence to Glaucoma Treatment During the COVID-19 Pandemic
por: Mylona, Ioanna, et al.
Publicado: (2021)

The Uses of Photodynamic Therapy Versus Anti-vascular Endothelial Growth Factor in the Management of Acute Central Serous Chorioretinopathy: A Systematic Review and Meta-Analysis
por: Seraj, Hadeel, et al.
Publicado: (2023)

Anti-vascular endothelial growth factor in the treatment of macular edema in epidemic retinitis
por: Kawali, Ankush A, et al.
Publicado: (2020)

Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry
por: Riemer, Tommes, et al.
Publicado: (2023)

A Critical Appraisal of New Developments in Intraocular Lens Modifications and Drug Delivery Systems for the Prevention of Cataract Surgery Complications
por: Mylona, Ioanna, et al.
Publicado: (2020)

Prevalence and Visual Consequences of Non-adherent Patients Receiving Anti-vascular Endothelial Growth Factor (VEGF) Injections at King Fahad Specialist Hospital (KFSH), Qassim Region
por: Alharbi, Abdulmajeed D, et al.
Publicado: (2023)

Pars Plana Vitrectomy With Internal Limiting Membrane Peeling for the Treatment of Cystoid Macular Edema in a Patient With Syphilitic Uveitis and HIV Infection
por: Pappaterra-Rodriguez, Mariella C, et al.
Publicado: (2022)

Cystoid macular edema in a child
por: Hamburger, Jordan, et al.
Publicado: (2020)

Conjunctival Pigmentation Following Pars Plana Vitrectomy (PPV) for Rhegmatogenous Retinal Detachment: Risk Factors and Outcomes
por: Dokos, Athanassios, et al.
Publicado: (2023)

Non-immediate drug hypersensitivity reactions secondary to intravitreal anti-vascular endothelial growth factors
por: Moret, E., et al.
Publicado: (2021)

Morphological Characteristics of Drug-Eluting Biodegradable Polymeric Thin Films Developed on the Surface of Intraocular Lenses by Three Techniques: A Comparative Study
por: Karamitsos, Athanasios, et al.
Publicado: (2021)

Commentary: Switching of anti-vascular endothelial growth factor agents in refractory diabetic macular edema
por: Ratra, Dhanashree
Publicado: (2021)

Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients
por: Li, Yun-Fei, et al.
Publicado: (2022)

Suspected Neratinib Macular Toxicity Presenting As Macular Telangiectasia Type II
por: Enghelberg, Moises, et al.
Publicado: (2023)

Clinical preferences and trends of anti‐vascular endothelial growth factor treatments for diabetic macular edema in Japan
por: Sugimoto, Masahiko, et al.
Publicado: (2018)

Intravitreal Anti-Vascular Endothelial Growth Factor for Macular Edema due to Complex Retinal Arterial Macroaneurysms
por: Bormann, Caroline, et al.
Publicado: (2017)

Anti-VEGF therapies in the treatment of choroidal neovascularisation secondary to non-age-related macular degeneration: a systematic review
por: Stuart, Arabella, et al.
Publicado: (2015)

Exploring challenges to nutrition intervention adherence using COM-B model among patients with wet age-related macular degeneration: a qualitative study
por: Bian, Wei, et al.
Publicado: (2022)

Hypertension is the Prominent Risk Factor in Cataract Patients
por: Mylona, Ioanna, et al.
Publicado: (2019)

Rasch Validation of the VF-14 Scale of Vision-Specific Functioning in Greek Patients
por: Mylona, Ioanna, et al.
Publicado: (2021)

Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
por: Mashima, Asako, et al.
Publicado: (2019)

Relief of Cystoid Macular Edema-Induced Focal Axonal Compression with Anti-Vascular Endothelial Growth Factor Treatment
por: Karahan, Eyyup, et al.
Publicado: (2020)

Identifying Genetic Biomarkers Predicting Response to Anti-Vascular Endothelial Growth Factor Injections in Diabetic Macular Edema
por: Gurung, Rajya L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3g8m3b7cfb9fgtfukvah5lp6kq